JP2009527485A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009527485A5 JP2009527485A5 JP2008555419A JP2008555419A JP2009527485A5 JP 2009527485 A5 JP2009527485 A5 JP 2009527485A5 JP 2008555419 A JP2008555419 A JP 2008555419A JP 2008555419 A JP2008555419 A JP 2008555419A JP 2009527485 A5 JP2009527485 A5 JP 2009527485A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- composition
- ror2
- agent
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77453406P | 2006-02-17 | 2006-02-17 | |
| US84423906P | 2006-09-13 | 2006-09-13 | |
| PCT/US2007/004510 WO2007098198A2 (en) | 2006-02-17 | 2007-02-16 | Modulation of bone formation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009527485A JP2009527485A (ja) | 2009-07-30 |
| JP2009527485A5 true JP2009527485A5 (https=) | 2011-03-24 |
Family
ID=38437973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555419A Withdrawn JP2009527485A (ja) | 2006-02-17 | 2007-02-16 | 骨形成の調節 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090047287A1 (https=) |
| EP (1) | EP1984395A2 (https=) |
| JP (1) | JP2009527485A (https=) |
| KR (1) | KR20080095269A (https=) |
| AR (1) | AR060104A1 (https=) |
| AU (1) | AU2007217779A1 (https=) |
| BR (1) | BRPI0707864A2 (https=) |
| CA (1) | CA2638803A1 (https=) |
| CR (1) | CR10212A (https=) |
| EC (1) | ECSP088682A (https=) |
| IL (1) | IL193271A0 (https=) |
| MX (1) | MX2008010511A (https=) |
| NO (1) | NO20083497L (https=) |
| PA (1) | PA8715601A1 (https=) |
| PE (1) | PE20071309A1 (https=) |
| RU (1) | RU2008131052A (https=) |
| SV (1) | SV2009002997A (https=) |
| TW (1) | TW200800266A (https=) |
| WO (1) | WO2007098198A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2566886A1 (en) * | 2010-05-05 | 2013-03-13 | Addex Pharma SA | Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily |
| WO2013070033A1 (ko) * | 2011-11-09 | 2013-05-16 | 주식회사 아이엠헬스케어 | 골다공증 및 골회전율 진단 스트립 |
| KR101354826B1 (ko) * | 2011-12-08 | 2014-01-27 | 아주대학교산학협력단 | 중간엽줄기세포 렙틴분비능을 이용한 골다공증 예방 또는 치료용 물질 스크리닝 방법 |
| US20140322234A1 (en) * | 2012-01-03 | 2014-10-30 | The Board Of Trustees Of The Leland Stanford Junior University | Analysis and Targeting of ROR2 in Cancer |
| JP6463029B2 (ja) * | 2013-08-02 | 2019-01-30 | 有未 伊谷 | ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法 |
| ES2927112T3 (es) * | 2014-08-01 | 2022-11-02 | Purec Co Ltd | Método para evaluar la calidad de células madre mesenquimatosas humanas y un anticuerpo monoclonal para su uso en dicho método |
| JP7057557B2 (ja) * | 2015-07-31 | 2022-04-20 | 国立大学法人大阪大学 | 上皮疾患に対する治療及び／又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤 |
| CN116751298A (zh) | 2016-05-13 | 2023-09-15 | 生物蛋白有限公司 | 抗ror2抗体、抗体片段和它们的免疫缀合物以及其用途 |
| GB201718985D0 (en) | 2017-11-16 | 2018-01-03 | Univ London Queen Mary | Treatment |
| US11793452B2 (en) | 2019-10-03 | 2023-10-24 | Johnson & Johnson Consumer Inc. | Method of visualizing and quantifying remineralization |
| CN115786252B (zh) * | 2023-02-07 | 2023-05-05 | 赛德特生物制药有限公司 | 人脐带间充质干细胞成骨诱导分化培养基及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312814A (en) * | 1992-12-09 | 1994-05-17 | Bristol-Myers Squibb Co. | α-phosphonocarboxylate squalene synthetase inhibitors |
| AU2001238571A1 (en) * | 2000-03-14 | 2001-09-24 | Regeneron Pharmaceuticals, Inc. | Methods of stimulating cartilage formation |
| EP1603586A1 (en) * | 2003-02-19 | 2005-12-14 | Aziz Ghahary | 14-3-3 protein for prevention and treatment of fibroproliferative disorders |
| AU2004233060A1 (en) * | 2003-04-16 | 2004-11-04 | Wyeth | A novel method of modulating bone-realted activity |
-
2007
- 2007-02-15 PE PE2007000174A patent/PE20071309A1/es not_active Application Discontinuation
- 2007-02-16 US US12/278,710 patent/US20090047287A1/en not_active Abandoned
- 2007-02-16 CA CA002638803A patent/CA2638803A1/en not_active Abandoned
- 2007-02-16 RU RU2008131052/13A patent/RU2008131052A/ru not_active Application Discontinuation
- 2007-02-16 EP EP07751280A patent/EP1984395A2/en not_active Withdrawn
- 2007-02-16 TW TW096106164A patent/TW200800266A/zh unknown
- 2007-02-16 MX MX2008010511A patent/MX2008010511A/es not_active Application Discontinuation
- 2007-02-16 BR BRPI0707864-1A patent/BRPI0707864A2/pt not_active IP Right Cessation
- 2007-02-16 AU AU2007217779A patent/AU2007217779A1/en not_active Abandoned
- 2007-02-16 PA PA20078715601A patent/PA8715601A1/es unknown
- 2007-02-16 AR ARP070100684A patent/AR060104A1/es not_active Application Discontinuation
- 2007-02-16 WO PCT/US2007/004510 patent/WO2007098198A2/en not_active Ceased
- 2007-02-16 JP JP2008555419A patent/JP2009527485A/ja not_active Withdrawn
- 2007-02-16 KR KR1020087021261A patent/KR20080095269A/ko not_active Withdrawn
-
2008
- 2008-08-05 IL IL193271A patent/IL193271A0/en unknown
- 2008-08-13 NO NO20083497A patent/NO20083497L/no not_active Application Discontinuation
- 2008-08-15 EC EC2008008682A patent/ECSP088682A/es unknown
- 2008-08-15 SV SV2008002997A patent/SV2009002997A/es unknown
- 2008-08-18 CR CR10212A patent/CR10212A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009527485A5 (https=) | ||
| AU2010305281B2 (en) | Siglec 15 antibodies in treating bone loss-related disease | |
| RU2008131052A (ru) | Модуляция костеобразования | |
| JP2010532360A (ja) | 骨障害の処置における使用のためのａｘｌのモジュレーター | |
| JP7231411B2 (ja) | 骨形成タンパク質６（ｂｍｐ６）の阻害剤を使用して疾患を処置する方法 | |
| CN103328500B (zh) | 用于癌症的诊断和治疗的方法和化合物 | |
| Mouton et al. | Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction | |
| Zhang et al. | Matrilin‐2 is a widely distributed extracellular matrix protein and a potential biomarker in the early stage of osteoarthritis in articular cartilage | |
| KR20190006548A (ko) | 항-인자 ix 파두아 항체 | |
| US7790161B2 (en) | GDF-9/BMP-15 modulators for the treatment of bone disorders | |
| JP2021500895A (ja) | Ａｌｋ７結合タンパク質およびその使用 | |
| Lehmann et al. | Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor | |
| WO2021149714A1 (ja) | 骨腫瘍の治療剤及び骨腫瘍等の治療のためのイオンチャネル作用薬の評価方法 | |
| Ray et al. | Identification of a novel 5-HT4 receptor splice variant (r5-HT4c1) and preliminary characterisation of specific 5-HT4a and 5-HT4b receptor antibodies | |
| JP2016104716A (ja) | 膵臓癌治療用のｃｄ９５シグナル伝達阻害化合物 | |
| Lee et al. | A non-ligand surrogate agonist antibody that enhances canonical Wnt signaling and bone regeneration | |
| Verma et al. | Amelioration of muscular dystrophy phenotype in mdx mice by inhibition of Flt1 | |
| Lee et al. | Exon 4-skipping GLT-1: a new form of an abundantly expressed glutamate transporter | |
| EP4626916A1 (en) | Targeting gpr158 (mglyr) with nanobodies for therapeutic benefits | |
| WO2025115644A1 (ja) | 運動ニューロン疾患の予後及び治療効果を予測する方法 | |
| WO2020181080A1 (en) | Biomarkers for treatment of cancer | |
| WO2011035045A1 (en) | Ion channel compositions and uses thereof |